$390.95
1.21%
NYSE, Oct 05, 04:04 pm EDT. Closed.
ISIN
US78409V1044
Symbol
SPGI

S&P Global Stock price

$390.92
-52.59 11.86% 1M
-19.69 4.79% 6M
-103.38 20.91% YTD
-61.53 13.60% 1Y
+49.20 14.40% 3Y
-11.19 2.78% 5Y
+273.49 232.90% 10Y
+337.73 634.89% 20Y
NYSE, Closing price Mon, Oct 05 2026
+4.65 1.20%
ISIN
US78409V1044
Symbol
SPGI
Industry

AI Insights on S&P Global Insights AI Insights on S&P Global

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is S&P Global a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
$113.9b
Enterprise Value
$124.9b
Net debt
$11.0b
Cash
$4.1b
Shares outstanding
294.8m
Valuation
P/E
23.2
P/S | estimate
7.1 | 7.5
EV/Sales | estimate
7.8 | 8.2
EV/FCF | ex SBC
22.4 | 23.4
P/B
3.6
Dividends
DPS
$3.78
Yield 1Y | 5Y
1.0% | 0.9%
Growth 1Y | 5Y
3.9% | 5.3%
Payout 1Y | 3Y
24.8% | 29.8%
Increased
25 Years
Financials
Revenue | estimate
$16.1b | $15.2b
EBITDA
$8.2b
EBIT
$7.0b
Net Income
$4.9b
Free Cash Flow | ex SBC
$5.6b | $5.3b
Growth
Revenue | estimate
9.7% | -1.2%
EBITDA
13.2%
EBIT
15.4%
Net Income
22.7%
Free Cash Flow
2.9%
Margin
Gross
63.6%
EBITDA
51.0%
EBIT
43.6%
Net
30.5%
Free Cash Flow | ex SBC
34.6% | 33.1%
Financial Health
Equity Ratio
50.9%
Return on Equity
14.4%
ROCE
13.1%
ROIC
10.3%
Debt/Equity
0.5
Share-Based Compensation & Dilution
SBC | % of Revenue
$239.0m | 1.5%
SBC as % of FCF
4.3%
SBC Growth 1Y
-7.0%
Share Count Growth 1Y
-3.4%
Shareholder Yield
4.4%
More
EPS
$16.7
FCF per Share
$18.9
Short interest
2.2%
Employees
45k
Rev per Employee
$340.0k

S&P Global Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a S&P Global forecast:

29x Buy
85%
5x Hold
15%

Analyst Opinions

34 Analysts have issued a S&P Global forecast:

Buy
85%
Hold
15%

S&P Global Events

Past Events
SEP
14
Barclays 24th Annual Global Financial Services Conference
21 days ago
JUL
28
Orbit as the Next Data Frontier: Capital Flows
2 months ago
JUL
28
Q2 2026 Earnings Call
2 months ago
JUL
22
GenAI Fundraising: From Private Rounds to Public Markets
3 months ago
JUN
10
Mizuho Technology Conference 2026
4 months ago
MAY
27
Bernstein 42nd Annual Strategic Decisions Conference
4 months ago
MAY
20
Shareholder/Analyst Call - S&P Global Inc.
5 months ago
MAY
12
Analyst/Investor Day - S&P Global Inc.
5 months ago
MAY
5
Barclays 18th Annual Americas Select Conference
5 months ago
APR
28
Q1 2026 Earnings Call
5 months ago
APR
6
Special Call - S&P Global Inc.
6 months ago
MAR
18
Reinventing AI Strategy for 2026
7 months ago
MAR
12
BofA Securities 2026 Information & Business Services Conference
7 months ago
MAR
3
47th Annual Raymond James Institutional Investor Conference
7 months ago
FEB
10
Q4 2025 Earnings Call
8 months ago
DEC
9
Goldman Sachs 2025 U.S. Financial Services Conference
10 months ago
NOV
18
J.P. Morgan 2025 Ultimate Services Investor Conference
11 months ago
NOV
13
Analyst/Investor Day - S&P Global Inc.
11 months ago
OCT
30
Q3 2025 Earnings Call
11 months ago
SEP
9
Barclays 23rd Annual Global Financial Services Conference
about one year ago

Financial data from S&P Global

Jun '26
+/-
%
16,121 16,121
10% 10%
100%
- Direct Costs 5,871 5,871
32% 32%
36%
10,250 10,250
0% 0%
64%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
8,226 8,226
13% 13%
51%
- Depreciation and Amortization 1,206 1,206
2% 2%
7%
EBIT (Operating Income) EBIT 7,020 7,020
15% 15%
44%
Net Profit 4,922 4,922
23% 23%
31%

In millions USD.

Don't miss a Thing! We will send you all news about S&P Global directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

S&P Global Stock News

Neutral
PRNewsWire
●
about one hour ago
NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Freshworks Inc. (NASD: FRSH) will replace BioLife Solutions Inc. (NASD:BLFS) in the S&P SmallCap 600 effective prior to the open of trading on Thursday, October 8. S&P MidCap 400 constituent Repligen Corp. (NASD:RGEN) is acquiring BioLife Solutions in a deal expected to be completed soon, pending final closing conditions.
Neutral
PRNewsWire
●
about 24 hours ago
New framework delivers independent risk transparency for onchain investment vehicles, furthering S&P Global's offerings across the DeFi space SINGAPORE, Oct. 4, 2026 /PRNewswire/ -- S&P Global Ratings, a division of S&P Global (NYSE: SPGI), today launched its Vault Risk Assessment (VRA), a new analytical approach that delivers independent, forward-looking insights into the risks associated with...
Neutral
PRNewsWire
●
6 days ago
NEW YORK, Sept. 29, 2026 /PRNewswire/ -- The Board of Directors of S&P Global (NYSE: SPGI) has approved a cash dividend on the Company's common stock for the fourth quarter of 2026.
More S&P Global News

Company Profile

S&P Global, Inc. engages in the provision of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide. It operates through the following segments: Ratings, Market Intelligence, Platts and Indices. The Ratings segment offers credit ratings, research, and analytics to investors, issuers, and other market participants. The Market Intelligence provides multi-asset-class data, research and analytical capabilities, which integrate cross-asset analytics and desktop services. The Platts segment provides information and benchmark prices for the commodity and energy markets. The Indices segment provides variety of valuation and index benchmarks for investment advisors, wealth managers and institutional investors. The company was founded by James H. McGraw and John A. Hill in 1917 and is headquartered in New York, NY.

Head office United States
CEO Ms. Cheung
Employees 44,500
Founded 1917
Website www.spglobal.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today